ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 3 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 2.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50,727 | -61.3% | 16,155 | +40.5% | 0.00% | – |
| Q2 2022 | $131,000 | -49.8% | 11,500 | -59.5% | 0.00% | – |
| Q1 2022 | $261,000 | +4.0% | 28,429 | +69.7% | 0.00% | – |
| Q4 2021 | $251,000 | -64.0% | 16,749 | -38.1% | 0.00% | -100.0% |
| Q3 2021 | $698,000 | -37.2% | 27,067 | -36.3% | 0.00% | 0.0% |
| Q2 2021 | $1,111,000 | +173.6% | 42,460 | +269.2% | 0.00% | – |
| Q1 2021 | $406,000 | +2.8% | 11,500 | -26.3% | 0.00% | -100.0% |
| Q4 2020 | $395,000 | -37.7% | 15,610 | -6.9% | 0.00% | 0.0% |
| Q3 2020 | $634,000 | +28.9% | 16,766 | +45.8% | 0.00% | 0.0% |
| Q2 2020 | $492,000 | +100.8% | 11,500 | -11.1% | 0.00% | 0.0% |
| Q1 2020 | $245,000 | – | 12,939 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
| Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
| TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
| Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
| DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
| Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
| Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
| Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
| Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |